Elena González‐Rey

11.7k total citations · 2 hit papers
106 papers, 6.2k citations indexed

About

Elena González‐Rey is a scholar working on Cellular and Molecular Neuroscience, Immunology and Molecular Biology. According to data from OpenAlex, Elena González‐Rey has authored 106 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 39 papers in Immunology and 28 papers in Molecular Biology. Recurrent topics in Elena González‐Rey's work include Neuropeptides and Animal Physiology (42 papers), Immunotherapy and Immune Responses (18 papers) and Chemokine receptors and signaling (15 papers). Elena González‐Rey is often cited by papers focused on Neuropeptides and Animal Physiology (42 papers), Immunotherapy and Immune Responses (18 papers) and Chemokine receptors and signaling (15 papers). Elena González‐Rey collaborates with scholars based in Spain, United States and United Kingdom. Elena González‐Rey's co-authors include Mario Delgado, Alejo Chorny, Laura G. Rico, Dirk Büscher, Doina Ganea, Per Anderson, Manuel A. González, Francisco O′Valle, Nieves Varela and Manuel González and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Elena González‐Rey

105 papers receiving 6.1k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

2009 537 citations Elena González‐Rey, Per Anderson et al. profile →
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses

2008 514 citations Elena González‐Rey, Mario Delgado et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena González‐Rey Spain	42	1.7k	1.6k	1.5k	1.4k	1.1k	106	6.2k
Renato Mantegazza Italy	51	1.0k 0.6×	927 0.6×	2.6k 1.7×	864 0.6×	784 0.7×	324	8.9k
Bjarne Winther Kristensen Denmark	45	1.7k 1.0×	860 0.5×	2.1k 1.4×	1.5k 1.1×	274 0.3×	217	6.9k
Klaus Addicks Germany	50	772 0.5×	849 0.5×	3.7k 2.4×	1.2k 0.9×	966 0.9×	199	8.4k
Tomohiro Matsuyama Japan	46	1.3k 0.8×	654 0.4×	2.5k 1.7×	1.3k 1.0×	473 0.4×	160	6.6k
Kiyoshi Ando Japan	48	2.3k 1.4×	2.1k 1.3×	2.8k 1.9×	497 0.4×	1.5k 1.4×	342	9.9k
Klaus V. Toyka Germany	50	742 0.4×	1.8k 1.1×	2.1k 1.4×	2.0k 1.5×	425 0.4×	144	8.7k
Alexander Birbrair United States	35	925 0.5×	653 0.4×	2.0k 1.3×	494 0.4×	458 0.4×	154	4.8k
Thomas Scholzen Germany	34	468 0.3×	1.1k 0.7×	2.4k 1.6×	597 0.4×	739 0.7×	65	7.4k
Werner Stenzel Germany	44	584 0.3×	1.4k 0.9×	1.9k 1.2×	613 0.5×	617 0.6×	235	6.4k
Fiorella Altruda Italy	50	936 0.6×	2.0k 1.3×	5.1k 3.4×	444 0.3×	466 0.4×	156	9.0k

Countries citing papers authored by Elena González‐Rey

Since Specialization

Citations

This map shows the geographic impact of Elena González‐Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena González‐Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena González‐Rey more than expected).

Fields of papers citing papers by Elena González‐Rey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena González‐Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena González‐Rey. The network helps show where Elena González‐Rey may publish in the future.

Co-authorship network of co-authors of Elena González‐Rey

This figure shows the co-authorship network connecting the top 25 collaborators of Elena González‐Rey. A scholar is included among the top collaborators of Elena González‐Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena González‐Rey. Elena González‐Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González‐Rey, Elena, et al.. (2024). Dopamine-loaded chitosan-coated solid lipid nanoparticles as a promise nanocarriers to the CNS. Neuropharmacology. 249. 109871–109871. 16 indexed citations

Ferraz-de-Paula, V., Marta Caro, Jenny Campos‐Salinas, et al.. (2024). Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease. International Journal of Molecular Sciences. 25(2). 694–694. 3 indexed citations

Luque, Raúl M., et al.. (2023). Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier. International Journal of Molecular Sciences. 24(18). 14117–14117. 5 indexed citations

Cavalcanti, Fernando, Elena González‐Rey, Mario Delgado, et al.. (2022). Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis. Pharmaceutics. 14(7). 1420–1420. 6 indexed citations

Martín-Malpartida, Pau, Elena González‐Rey, Eric Aragón, et al.. (2021). Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease. Nature Communications. 12(1). 1869–1869. 23 indexed citations

Belmonte‐Reche, Efres, Pablo Peñalver, Marta Caro, et al.. (2021). Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases. European Journal of Medicinal Chemistry. 223. 113655–113655. 20 indexed citations

Benítez, Raquel, Marta Caro, María Morell, et al.. (2021). The Neuropeptide Cortistatin Alleviates Neuropathic Pain in Experimental Models of Peripheral Nerve Injury. Pharmaceutics. 13(7). 947–947. 8 indexed citations

Peñalver, Pablo, Efres Belmonte‐Reche, Norma Adán, et al.. (2018). Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases. European Journal of Medicinal Chemistry. 146. 123–138. 63 indexed citations

Benítez, Raquel, Marta Caro, Mario Durán‐Prado, et al.. (2018). Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. The Journal of Immunology. 200(11). 3697–3710. 18 indexed citations

10.

Anderson, Per, Elena González‐Rey, Francisco O′Valle, et al.. (2017). Allogeneic Adipose-Derived Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Regulating Self-Reactive T Cell Responses and Dendritic Cell Function. Stem Cells International. 2017. 1–15. 41 indexed citations

11.

Souza‐Moreira, Luciana, et al.. (2013). Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells. Brain Behavior and Immunity. 30. 54–60. 29 indexed citations

12.

Prasse, Antje, Gernot Zissel, Niklas Lützen, et al.. (2010). Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 182(4). 540–548. 115 indexed citations

13.

Roodveldt, Cintia, Adahir Labrador‐Garrido, Elena González‐Rey, et al.. (2010). Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants. PLoS ONE. 5(10). e13481–e13481. 81 indexed citations

14.

Delgado, Mario, Miguel G. Toscano, Karim Benabdellah, et al.. (2008). In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen‐induced arthritis. Arthritis & Rheumatism. 58(4). 1026–1037. 39 indexed citations

15.

Benabdellah, Karim, Elena González‐Rey, & Antonio González. (2007). Alternative trans ‐splicing of the Trypanosoma cruzi LYT1 gene transcript results in compartmental and functional switch for the encoded protein. Molecular Microbiology. 65(6). 1559–1567. 25 indexed citations

16.

González‐Rey, Elena, et al.. (2006). Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proceedings of the National Academy of Sciences. 103(11). 4228–4233. 95 indexed citations

17.

González‐Rey, Elena, Alejo Chorny, & Mario Delgado. (2006). VIP: An Agent with License to Kill Infective Parasites. Annals of the New York Academy of Sciences. 1070(1). 303–308. 20 indexed citations

18.

González‐Rey, Elena & Mario Delgado. (2006). Therapeutic Treatment of Experimental Colitis With Regulatory Dendritic Cells Generated With Vasoactive Intestinal Peptide. Gastroenterology. 131(6). 1799–1811. 77 indexed citations

19.

González‐Rey, Elena, Alejo Chorny, & Mario Delgado. (2006). Therapeutic Action of Ghrelin in a Mouse Model of Colitis. Gastroenterology. 130(6). 1707–1720. 222 indexed citations

20.

Delgado, Mario, Elena González‐Rey, & Doina Ganea. (2005). The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells. The Journal of Immunology. 175(11). 7311–7324. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact